United States DHA Supplements Market Set for Robust Expansion Fueled by Brain & Eye Health Awareness and Surge in Sustainable Algal-Based DHA Consumption

Leander, Texas and TOKYO, Japan - Dec.04. 2025 "The DHA Supplements Market was valued at US$ 1.4 billion in 2022 and is projected to reach US$ 2.3 billion by 2030, growing at a CAGR of 6.5% during the forecast period 2024-2030."

The DHA Supplements Market is driven by growing consumer awareness of DHA's critical role in brain, eye, and heart health, particularly for prenatal, infant, and cognitive support, alongside rising demand for vegan and sustainable algal sources. Market growth is bolstered by clinical research validating DHA's benefits in reducing inflammation and supporting mental wellness, expanded R&D in bioavailable formulations, and e-commerce proliferation amid aging populations and post COVID health focus.

➠ Download Your Sample Report Instantly - Corporate Email ID Required for Priority Access: https://www.datamintelligence.com/download-sample/dha-supplements-market?praneetha

☛ Recent Industry Developments :
United States :
✅ December 2025: DSM Nutritional Products launched a new algal DHA softgel line, VitaDHA Pro, delivering 500 mg per serving with enhanced bioavailability for cognitive health. Backed by a $45 million investment in U.S. production facilities, the rollout targets prenatal and senior markets to align with FDA's omega-3 guidelines and boost sales by 18% in 2026.

✅ November 2025: Nordic Naturals expanded its Prenatal DHA portfolio with a vegan algal variant, incorporating 400 IU Vitamin D3 and choline for fetal brain development. Supported by $30 million in R&D and partnerships with major pharmacies, the product aims to capture 15% of the U.S. maternal supplement segment.

✅ October 2025: BASF Corporation acquired a stake in a California based microalgae startup to scale krill free DHA powders for infant formulas. The $25 million deal includes clinical trials for ADHD support, targeting pediatric nutrition leaders like Abbott.

Global :
✅ December 2025 : Corbion and Lonza announced a joint venture for sustainable algal DHA production, launching a 600 mg capsule for global vegan markets. Supported by €60 million ($65 million) in EU and U.S. funding, the initiative emphasizes carbon neutral sourcing.

✅ November 2025 : Pharma Marine AS secured $40 million in Series B funding to commercialize krill DHA hybrids for cardiovascular applications, with trials in Europe and Asia for 20% efficacy gains.

✅ October 2025: Croda International Plc collaborated with a Brazilian biotech to introduce biofortified DHA from microalgae for sports nutrition, backed by $35 million for South American and APAC expansions.

☛ Core Catalysts Behind Market Growth:
Heightened health consciousness post COVID, with DHA's anti inflammatory properties linked to reduced mortality risk (e.g., 2021 ASM studies), driving demand in immune and cognitive supplements.

Surge in prenatal and infant nutrition, supported by research on DHA's role in brain development (e.g., 2021 studies proving essentials for pregnancy), boosting algal and fish oil formulations.

Shift toward vegan and sustainable options, with algal DHA growing 12% YoY due to ethical sourcing and lower contaminants, aligned with global eco labels.

Aging demographics and mental health focus, including ADHD and dementia prevention, amplified by e-commerce accessibility and personalized dosing innovations.

➠ Get Customization in the Report as per Your Requirements:
https://www.datamintelligence.com/customize/dha-supplements-market?praneetha

☛ Market Segmentation :
By Source :
Fish Oil dominates with 55% share, propelled by its rich EPA/DHA profile and proven benefits for heart, brain, and eye health, backed by extensive clinical data (e.g., 2021 studies on cognitive development) and affordability for mass-market consumers seeking general wellness support.

Algal Oil holds 25%, rapidly expanding in vegan and sustainable segments with contaminant free production via innovations like Corbion's Algal Omega-3 (launched May 2023), ideal for prenatal and pediatric applications amid rising plant-based diet trends.

Krill Oil accounts for 15%, favored for superior phospholipid bound absorption targeting joint, cardiovascular, and cognitive wellness, with growth driven by premium formulations for targeted health claims.

Others (e.g., seaweed extracts) represent 5%, emerging in niche functional foods and sustainable blends for eco-conscious consumers.

By Form :
Capsules lead with 48% share, offering convenience, precise dosing, and stability for daily routines, particularly in adult and senior demographics for brain and eye health maintenance.

Liquids capture 30%, driven by easy integration into smoothies, infant formulas, and beverages for improved compliance in children and prenatal users, with flavored variants enhancing palatability.

Powders hold 22%, gaining traction in fortified foods and baking mixes for versatile, flavor masked delivery, supported by advancements like DSM's DHASCO-B lipid powder (launched March 2021) for cognitive and infant nutrition.

By Application :
Nutritional supplement command 60% share, fueled by direct to consumer trends for brain, cognitive, and eye health amid rising wellness spending and post-COVID health focus.

Pharmaceuticals account for 20%, integrated into prescription nutraceuticals for targeted uses like ADHD management and prenatal care, backed by clinical validations.

Food and Beverages represent 15%, with DHA-enriched milks, bars, and infant formulas driving functional nutrition growth, exemplified by launches like Nordic Naturals Prenatal DHA (March 2023).

Others (e.g., animal feed, cosmetics) hold 5%, supporting aquaculture sustainability and emerging skincare applications for anti inflammatory benefits.

By Distribution Channel :
Pharmacy and Drug Stores hold 35% share, trusted for quality assurance, pharmacist consultations, and health claim validations in regulated markets.

Grocery Stores capture 25%, enabling impulse buys and accessibility for everyday fortified products in mainstream retail.

Specialty Stores (e.g., Nutritional supplement Stores) account for 22%, catering to niche vegan, organic, and premium seekers with expert advice and curated selections.

Others (e.g., Online Platforms) represent 18%, accelerated by e-commerce giants like Amazon for personalized recommendations and global reach.

☛ Competitive Landscape:
The DHA Supplements Market is competitive, with biotech innovators and nutritional giants vying through sustainable sourcing, bioavailability enhancements, and targeted launches for prenatal/cognitive niches.

DSM Nutritional Products leads with an estimated 24% share, dominating algal DHA via DHASCO innovations and reporting 14% YoY growth from prenatal expansions in 2024-2025.

BASF Corporation holds around 20% market share, leveraging omega-3 portfolios and strategic acquisitions for fish/krill blends in North America.

Croda International Plc secures approximately 16% share, excelling in algal powders under its PRAPurify tech for clean label pharmaceuticals.

Pharma Marine AS captures 13% share, focusing on krill-DHA for premium absorption and gaining 11% through EU sustainability certifications.

Nordic Naturals commands 12% share, innovating flavored liquids and Chewable supplements for U.S. consumers, with strong e-commerce penetration.

➠ Purchase this report before year end and unlock an exclusive 30% discount :

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=dha-supplements-market?praneetha
(Purchase 2 or more Reports and get 50% Discount)

☛Regional Analysis :
North America :
North America dominates with 31%, powered by high prenatal supplement adoption, algal oil trends in the U.S./Canada, and clinical awareness of DHA for cognitive/eye health, supported by NIH-funded research and $2 billion in annual omega-3 sales.

Europe :
Europe holds 25%, driven by EFSA-approved claims for brain development, vegan algal surges in Germany/UK, and EU Green Deal incentives for sustainable sourcing amid 10% YoY growth in functional foods.

Asia Pacific :
Asia Pacific accounts for 28%, the fastest growing region fueled by Japan's elderly cognitive focus, India's rising middle class wellness spending, and China's infant formula mandates, with investments exceeding $500 million in algal tech.

South America :
South America represents 8%, with Brazil leading via fortified dairy and fish oil affordability for maternal health, bolstered by PAHO guidelines and e-commerce expansion.

Middle East :
The Middle East holds 5%, supported by UAE/Saudi health tourism and imported algal DHA for expatriate prenatal needs.

Africa :
Africa accounts for 3%, concentrated in South Africa's urban supplements for child development, with gradual uptake via NGO nutrition programs.

➠ Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Market Access Snapshots
✅ Emerging Risks & Market Volatility Analysis
✅ Quarterly Updated Reports
✅ Live Market & Pricing Trends
✅ Import Export Data Monitoring

Company Name: DataM Intelligence 4Market Research LLP
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

DataM Intelligence is a global Market Research and Consulting firm providing comprehensive business insights and end-to-end solutions from research to consulting. We deliver actionable intelligence across 6,300+ reports spanning 40+ domains, empowering over 200 companies in 50+ countries. Our focus is on enabling clients to make data-driven decisions through robust methodologies, strategic foresight, and real-time market intelligence.

This release was published on openPR.